Network and Systems Medicine is the premier open access, peer-reviewed journal focused on interdisciplinary approaches to exploiting the power of big data by applying network science and systems thinking to medicine. Network and Systems Medicine yields major breakthroughs towards mechanism-based re-definitions of diseases for high-precision diagnostics and treatments.
Network and Systems Medicine is the premier open access, peer-reviewed journal focused on interdisciplinary approaches to exploiting the power of big data by applying network science and systems thinking to medicine. Network and Systems Medicine yields major breakthroughs towards mechanism-based re-definitions of diseases for high-precision diagnostics and treatments.
Network and Systems Medicine publishes high quality basic science, translational, and clinical research in the form of original research articles, comprehensive review articles, mini-reviews, rapid communications, brief reports, technology reports, hypothesis articles, perspectives, and letters to the editor. The Journal publishes under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation. All articles submitted to Systems Medicine are rapidly reviewed and published online within 4-5 weeks after acceptance. Network and Systems Medicine is fully NIH-, HHMI- and Wellcome Trust compliant.
Network and Systems Medicine coverage includes:
Audience: Biomedical researchers and cell biologists; multi-omics biotechnology researchers; network scientists; systems biologists; precision medicine (nutrigenomics, pharmacogenomics) scientists; bioinformaticians and computational biologists; clinicians, medical doctors, nurses, healthcare professionals; industry scientists (pharma, diagnostics); regulatory, government and policymakers; scholars in global health, among others.
Benefits of publishing in the Journal include:
Network and Systems Medicine is under the editorial leadership of Co-Editors-in-Chief Harald H.H.W. Schmidt, MD, PhD, PharmD, Professor of Pharmacology, Chairman Department of Pharmacology and Personalised Medicine, Maastricht University, and Jan Baumbach, PhD, Professor and Chairman of Experimental Bioinformatics, Technical University of Munich, Germany; and Senior Associate Editors, Albert-Laszlo Barabasi, PhD, Northeastern University, Boston, MA, and Joseph Loscalzo, MD, PhD, Harvard University, Boston, MA.